Aspire Biopharma and Microsize collaborate for alprazolam powder formulation

Aspire Biopharma’s new sublingual powder bypasses digestion, delivering alprazolam directly for faster anxiety and panic ...
Yahoo Finance

Active Pharmaceutical Ingredients (API) Directory 2026: Access Extensive Information on Over 5,000 API Companies and 25,000 Executives Worldwide

Dublin, Feb. 10, 2026 (GLOBE NEWSWIRE) -- The "Active Pharmaceutical Ingredients Directory" directory has been added to ResearchAndMarkets.com's offering. Published annually the Active Pharmaceutical ...

Aspire Biopharma Partners with Microsize to Develop Rapid-delivery Sublingual Powder Formulation of Alprazolam for Faster Anxiety Relief

Collaboration aims to create the first-ever sublingual alprazolam powder, addressing the need for faster-acting anxiety ...
pharmaphorum

Innovation in generics: Increased efficiency through peptide API synthesis expertise

With the healthcare landscape continually evolving, the generic medicines industry guarantees widespread access to affordable medications for millions of patients worldwide. Generics play a pivotal ...
BioSpace

AbbVie Backs Obesity Push With $380M API Production Expansion Project in Illinois

Part of AbbVie’s vow to invest $100 billion in the U.S. over the next decade, the two Illinois facilities will make active ingredients for next-generation neuroscience and obesity drugs when they ...
Sydney Morning Herald

The endurance of overnight Weet-Bix: Is this viral make-ahead breakfast worth the hype?

Breakfast cereal wheat biscuits are an oddly divisive thing: you either love their simplicity, or think they taste like cardboard. As someone firmly in the latter camp, I’ve been fascinated by the ...
FiercePharma

Hims retreats from weight loss pill launch as Novo, FDA pressure mounts

Hims & Hers caused a firestorm last week when it revealed that it planned to launch a knockoff version of Novo Nordisk's new oral weight loss medicine. But the reaction to the move has caused the ...